← Eichor
Condition: Progression Free Survival Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Progression Free Survival

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

CompArative Analysis Between, Thymic, pulmonaRy and Pancreatic Well Differentiated High Grade Neuroendocrine Tumors
Phase N/A · 1 location(s) · European Institute of Oncology · NCT07429851Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)
Phase 1/Phase 2 · 4 location(s) · Amsterdam UMC, location VUmc · NCT06384560Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic Leukemia
Phase N/A · 1 location(s) · Hospital General de Mexico · NCT07258043Impact of Using the Oncogramme® Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Can
NA · 1 location(s) · Oncomedics · NCT05299840Working Out M0 Bipolar Androgen Therapy
Phase 2 · 12 location(s) · Australian and New Zealand Urogenital and Prostate Cancer Tr · NCT06594926A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compar
Phase 3 · 187 location(s) · BeOne Medicines · NCT06943872Long-term Follow-up of Subjects Treated With CAR T Cells
Phase N/A · 1 location(s) · Marcela V. Maus, M.D.,Ph.D. · NCT05024175A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT
Phase N/A · 2 location(s) · Chang Gung Memorial Hospital · NCT04805255Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers
Phase 2 · 10 location(s) · Centre Hospitalier Universitaire de Besancon · NCT06425133Prognostic Analyses on a Validation Series of Patients With Waldenström's Disease
Phase N/A · 15 location(s) · French Innovative Leukemia Organisation · NCT05911802A Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophag
Phase 3 · 1 location(s) · Renmin Hospital of Wuhan University · NCT05919030The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
NA · 5 location(s) · Jasper Gerritsen · NCT03861299A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial
NA · 1 location(s) · Zhujiang Hospital · NCT06215495Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC
Phase 2 · 1 location(s) · Henan Cancer Hospital · NCT05918328Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors
Phase 2 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT04933669Atovaquone Combined With Radiation in Children With Malignant Brain Tumors
Phase 1 · 2 location(s) · Emory University · NCT06624371Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy
Phase 2/Phase 3 · 1 location(s) · Chang Gung Memorial Hospital · NCT03534050Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06487481The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
Phase N/A · 8 location(s) · Jasper Gerritsen · NCT06283927Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-inten
Phase 2 · 10 location(s) · University of Liege · NCT03852407A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizu
Phase 2 · 13 location(s) · Centre Leon Berard · NCT05152472De-escalation Study for Stage IIa/IIb < 3 cm Seminoma
Phase 2 · 15 location(s) · Centre Leon Berard · NCT05529251Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）
Phase 2 · 1 location(s) · The Affiliated Hospital of Qingdao University · NCT06647680Real-World Comparison of Chemo-Immunotherapy Regimens in Metastatic NSCLC With PD-L1 <50% (ALCG-01)
Phase N/A · 2 location(s) · Gazi University · NCT07394062Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas
NA · 16 location(s) · Centre Leon Berard · NCT04055220ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
Phase 3 · 4 location(s) · Newave Pharmaceutical Inc · NCT07342478PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Color
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05286814Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma
Phase N/A · 1 location(s) · FengYan Jin · NCT06252792Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective M
Phase N/A · 5 location(s) · Medical University of Silesia · NCT07120529Predictive Factors for Survival in Aggressive Meningiomas
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05793034
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.